132 related articles for article (PubMed ID: 22186081)
1. The endocannabinoid N-arachidonoyldopamine (NADA) exerts neuroprotective effects after excitotoxic neuronal damage via cannabinoid receptor 1 (CB(1)).
Grabiec U; Koch M; Kallendrusch S; Kraft R; Hill K; Merkwitz C; Ghadban C; Lutz B; Straiker A; Dehghani F
Neuropharmacology; 2012 Mar; 62(4):1797-807. PubMed ID: 22186081
[TBL] [Abstract][Full Text] [Related]
2. 2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells.
Kreutz S; Koch M; Böttger C; Ghadban C; Korf HW; Dehghani F
Glia; 2009 Feb; 57(3):286-94. PubMed ID: 18837048
[TBL] [Abstract][Full Text] [Related]
3. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures.
Kreutz S; Koch M; Ghadban C; Korf HW; Dehghani F
Exp Neurol; 2007 Jan; 203(1):246-57. PubMed ID: 17010339
[TBL] [Abstract][Full Text] [Related]
5. TRPV1 and CB(1) receptor-mediated effects of the endovanilloid/endocannabinoid N-arachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat.
Sagar DR; Smith PA; Millns PJ; Smart D; Kendall DA; Chapman V
Eur J Neurosci; 2004 Jul; 20(1):175-84. PubMed ID: 15245490
[TBL] [Abstract][Full Text] [Related]
6. Anandamide and NADA bi-directionally modulate presynaptic Ca2+ levels and transmitter release in the hippocampus.
Köfalvi A; Pereira MF; Rebola N; Rodrigues RJ; Oliveira CR; Cunha RA
Br J Pharmacol; 2007 Jun; 151(4):551-63. PubMed ID: 17435795
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA).
O'Sullivan SE; Kendall DA; Randall MD
Br J Pharmacol; 2004 Mar; 141(5):803-12. PubMed ID: 14769783
[TBL] [Abstract][Full Text] [Related]
8. Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-α.
Koch M; Kreutz S; Böttger C; Benz A; Maronde E; Ghadban C; Korf HW; Dehghani F
Neurotox Res; 2011 Feb; 19(2):330-40. PubMed ID: 20221904
[TBL] [Abstract][Full Text] [Related]
9. Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB receptors.
Millns PJ; Chimenti M; Ali N; Ryland E; de Lago E; Fernandez-Ruiz J; Chapman V; Kendall DA
Eur J Neurosci; 2006 Dec; 24(12):3489-95. PubMed ID: 17229097
[TBL] [Abstract][Full Text] [Related]
10. The antinociceptive potency of N-arachidonoyl-dopamine (NADA) and its interaction with endomorphin-1 at the spinal level.
Farkas I; Tuboly G; Benedek G; Horvath G
Pharmacol Biochem Behav; 2011 Oct; 99(4):731-7. PubMed ID: 21624393
[TBL] [Abstract][Full Text] [Related]
11. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
[TBL] [Abstract][Full Text] [Related]
12. Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.
Sagar DR; Jhaveri MD; Richardson D; Gray RA; de Lago E; Fernández-Ruiz J; Barrett DA; Kendall DA; Chapman V
Eur J Neurosci; 2010 Apr; 31(8):1414-22. PubMed ID: 20384778
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoids exert CB
Xu C; Hermes DJ; Nwanguma B; Jacobs IR; Mackie K; Mukhopadhyay S; Lichtman AH; Ignatowska-Jankowska B; Fitting S
Mol Cell Neurosci; 2017 Sep; 83():92-102. PubMed ID: 28733129
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid CB(1) receptor activation stimulates neurite outgrowth and inhibits capsaicin-induced Ca(2+) influx in an in vitro model of diabetic neuropathy.
Zhang F; Challapalli SC; Smith PJ
Neuropharmacology; 2009 Aug; 57(2):88-96. PubMed ID: 19501110
[TBL] [Abstract][Full Text] [Related]
15. N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors.
Marinelli S; Di Marzo V; Florenzano F; Fezza F; Viscomi MT; van der Stelt M; Bernardi G; Molinari M; Maccarrone M; Mercuri NB
Neuropsychopharmacology; 2007 Feb; 32(2):298-308. PubMed ID: 16760924
[TBL] [Abstract][Full Text] [Related]
16. Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta.
Freestone PS; Guatteo E; Piscitelli F; di Marzo V; Lipski J; Mercuri NB
Neuropharmacology; 2014 Apr; 79():467-75. PubMed ID: 24334069
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons.
Ohno-Shosaku T; Hashimotodani Y; Ano M; Takeda S; Tsubokawa H; Kano M
J Physiol; 2007 Oct; 584(Pt 2):407-18. PubMed ID: 17615096
[TBL] [Abstract][Full Text] [Related]
18. Protective Effect of N-Arachidonoyl Glycine-GPR18 Signaling after Excitotoxical Lesion in Murine Organotypic Hippocampal Slice Cultures.
Grabiec U; Hohmann T; Ghadban C; Rothgänger C; Wong D; Antonietti A; Groth T; Mackie K; Dehghani F
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871175
[TBL] [Abstract][Full Text] [Related]
19. Increased depressor response to N-arachidonoyl-dopamine during high salt intake: role of the TRPV1 receptor.
Wang Y; Wang DH
J Hypertens; 2007 Dec; 25(12):2426-33. PubMed ID: 17984664
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoid transport tightly controls 2-arachidonoyl glycerol actions in the hippocampus: effects of low temperature and the transport inhibitor AM404.
Hájos N; Kathuria S; Dinh T; Piomelli D; Freund TF
Eur J Neurosci; 2004 Jun; 19(11):2991-6. PubMed ID: 15182306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
